Perioperative acute upper gastrointestinal haemorrhage in older patients with hip fracture: Incidence, risk factors and prevention

29Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: No specific preventive strategy exists for acute gastrointestinal haemorrhage in hip fracture patients. Aims: To determine the effectiveness of prophylactic use of proton pump inhibitors in patients with risk factors for acute gastrointestinal haemorrhage. Methods: Prospective two-stage study of 822 consecutive older (≥60 years) hip fracture patients. Results: Acute gastrointestinal haemorrhage occurred in 16 (3.9%) of 407 patients and was associated with increased length of hospital stay (28.7 vs. 15.9; P = 0.0027) and mortality (18.8% vs. 4.3%; P = 0.043). Multiple analysis identified five independent risk factors for acute gastrointestinal haemorrhage: pre-existing peptic ulcer (OR 4.3; P = 0.043), current smoking (OR 3.1; P = 0.023), post-operative use of an antiplatelet agent (OR 6.5; P = 0.046), post-operative use of non-steroidal anti-inflammatory drug/cyclo-oxygenase-2 inhibitor (OR 4.9; P = 0.06) and blood group O (OR 1.7; P = 0.046). These risk factors were highly sensitive and had a negative predictive value of 99.8%. Prophylactic use of proton pump inhibitors in patients with risk factor for acute gastrointestinal haemorrhage significantly reduced the incidence of this complication (0.72% in treated patients vs. 13.4% in untreated; P < 0.001); the number needed to treat was 7.9. Conclusions: In older hip fracture patients perioperative acute gastrointestinal haemorrhage occurs in 3.9% and is associated with poor outcome. Preventive proton pump inhibitor therapy in patients at risk of acute gastrointestinal haemorrhage is effective and safe. © 2007 The Authors.

Cite

CITATION STYLE

APA

Fisher, L., Fisher, A., Pavli, P., & Davis, M. (2007). Perioperative acute upper gastrointestinal haemorrhage in older patients with hip fracture: Incidence, risk factors and prevention. Alimentary Pharmacology and Therapeutics, 25(3), 297–308. https://doi.org/10.1111/j.1365-2036.2006.03187.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free